home / stock / atos / atos articles

ATOS Articles, Atossa Therapeutics Inc.

Stock Information
Company Name: Atossa Therapeutics Inc.
Stock Symbol: ATOS
Market: NASDAQ
Website: atossatherapeutics.com
Menu
ATOS ATOS Quote ATOS Short ATOS News ATOS Articles ATOS Message Board
Get ATOS Alerts

News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer | Benzinga

SEATTLE, July 02, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), today announced the appointment ...
Atossa to Present at the Sidoti Small-Cap Investor Conference | Benzinga

SEATTLE, June 05, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), today announced that the Company...

Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen | Benzinga

SEATTLE, April 29, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company") today announced an expanded rese...

Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference | Benzinga

SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company") today announced that Chief Execu...
Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors | Benzinga

SEATTLE, March 12, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical stage biopharmaceuti...

Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director | Benzinga

SEATTLE, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical stage biopharmaceutical company developing innova...

Atossa Therapeutics Appoints Financial Executive Jonathan Finn to its Board of Directors | Benzinga

SEATTLE, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical stage biopharmaceutical company developing innova...
Atossa to Present at Cantor Fitzgerald Global Healthcare Conference 2023 | Benzinga

SEATTLE, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical stage biopharmaceutical company developing innov...

Breast Cancer-Focused Atossa Therapeutics Can Possibly Change Treatment Paradigm: Analyst | Benzinga

Cantor Fitzgerald has initiated coverage of Atossa Therapeutics Inc (NASDAQ: ATOS) with an Overweight rating and a price target...

Next 10